144 ·Filed Jun 26, 2026

PSNL

Personalis, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago SEC0001950047-26-006545
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This 144 is a scheduled execution under a long-standing 10b5-1 plan, not a discretionary bearish signal. The filing does not alter the fundamental thesis. Monitor for any accelerated selling outside the plan or insider departures.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
PSNL ▲ +18.98% at T+60d
NEUTRAL call ✓ call won +18.98% · α vs SPY +14.60% · entry $13.75 → $16.36
Entry anchored
Jun 26, 03:59 PM ET
via exchange tick
T+1d
-2.55%
call -2.55% · α -3.32%
$13.40
settled 3mo ago
T+5d
+4.29%
call +4.29% · α +2.90%
$14.34
settled 3mo ago
T+20d
-14.33%
call -14.33% · α -14.05%
$11.78
settled 2mo ago
T+60d
+18.98%
call +18.98% · α +14.60%
$16.36
settled 10d ago

Price Chart

Loading chart...

Executive Summary

Personalis CFO Aaron Tachibana filed a Form 144 on June 26, 2026, to sell 51,251 shares of common stock, valued at approximately $645,250, via a pre-arranged 10b5-1 trading plan. The plan also shows two prior sales within the last 60 days totaling $929,857. This is a planned, non-discretionary sale under a Rule 10b5-1 plan and does not signal a change in outlook.

Key Facts

  • CFO Aaron Tachibana filed a Form 144 to sell 51,251 shares valued at ~$645,250.
  • The sale is executed under a pre-established 10b5-1 trading plan dated August 7, 2025.
  • Two prior plan sales occurred in May and June 2026 (78,799 shares for ~$929,857).
  • Total planned sale value is ~$645,250, which is modest relative to the company's $1.3B market cap (~0.05%).
  • The sale is via Morgan Stanley Smith Barney for cash proceeds from the exercise of stock options.

Financial Impact

Sale of 51,251 shares at ~$645,250 — less than 0.05% of market cap; immaterial dilution risk.

dilution

Risk Factors

  • Broader insider selling pattern if other executives file 144s outside their plans.
  • Stock price weakness from mechanical selling, though the size is small.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006545
Document: 0001950047-26-006545-index.html0001950047-26-006545
Document: 0001950047-26-006545.txt0001950047-26-006545
14 reports for PSNL
Performance horizon
100% Hit rate 6 of 6 directional calls best @ T+20▲ +14.48%Aug 9, 2026
Filters
Rows
Reports for PSNL — sortable, filterable
TypeNow
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 6/10
$14.50 $16.60▲ +14.48%▲ +15.40%$16.28 (+12.28%)
Jul 20, 2026
10w ago
425
BULLISH ★ 7/10
$13.44 $13.91▲ +3.50%▲ +0.94%$16.28 (+21.13%)
Jul 20, 2026
10w ago
8-K
NEUTRAL ★ 6/10
$13.44 $13.91▲ +3.50%▲ +0.94%$16.28 (+21.13%)
Jul 20, 2026
10w ago
425
BULLISH ★ 7/10
$13.34 $13.89▲ +4.12%▲ +0.00%$16.28 (+22.04%)
Jul 20, 2026
10w ago
8-K
BULLISH ★ 7/10
$13.34 $13.89▲ +4.12%▲ +0.00%$16.28 (+22.04%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 4/10
$15.58 $14.42▼ −7.45%▼ −11.06%$16.28 (+4.49%)
Jun 29, 2026
13w ago
144
NEUTRAL ★ 2/10
$13.40 $11.98▼ −10.60%▼ −9.57%$16.28 (+21.49%)
Jun 26, 2026
14w ago
144
NEUTRAL ★ 3/10
$13.75 $11.78▼ −14.33%▼ −14.05%$16.28 (+18.40%)
Jun 26, 2026
14w ago
144
NEUTRAL ★ 2/10
$13.75 $11.78▼ −14.33%▼ −14.05%$16.28 (+18.40%)
Jun 6, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$10.04 $14.34▲ +42.83%▲ +41.20%$16.28 (+62.15%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (64h 18m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access